Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

Crispr Therapeutics AG (CRSP) stock saw a modest uptick, ending the day at $40.49 which represents a slight increase of $0.49 or 1.23% from the prior close of $40. The stock opened at $40 and touched ...

Stem cell engineering and CRISPR were used to create mice with two male parents. Could we use this technique on humans?

Group Dinner Meeting to be held in New York on February 5 at 6 pm hosted by Truist. Maximize Your Portfolio with Data Driven Insights:Leverage ...

By treating DNA as a language, Brian Hie’s “ChatGPT for genomes” could pick up patterns that humans can’t see, accelerating ...

EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) today Published first on TheFly – the ultimate source for ...

Cancer is rarely discussed alongside liposuction or plastic surgery. However, a groundbreaking approach to cancer treatment ...

In recent scientific breakthroughs, fossils of a waterfowl dating back to the dinosaur era were discovered in Antarctica, revealing this bird as the oldest 'modern' bird ancestor. Research also has ...

Study reveals the impact of X chromosome on brain aging in women. Learn how maternal and paternal X chromosome can influence ...

Newco Akribion Therapeutics GmbH has raised €8 million (US$8.3 million) in a seed round to develop a new and potent class of RNA-targeted CRISPR nucleases, which, rather than cleaving specific nucleic ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

The Genetic Disorders Health Center is a comprehensive and trusted resource for all topics related to Genetic Disorders Health and wellness. It includes articles, news, videos, animations, quizzes, ...